Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutations in the ATP-sensitive K(+) channel (KATP channel). We investigated the interactions between MgATP, MgADP, and the sulphonylurea gliclazide with KATP channels expressed in Xenopus oocytes. In the abse...
Những tác giả chính: | Proks, P, De Wet, H, Ashcroft, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2013
|
Những quyển sách tương tự
-
Phentolamine block of ATP-sensitive K+ channels does not involve interaction with the sulphonylurea receptor, SUR1.
Bằng: Proks, P, et al.
Được phát hành: (1997) -
Interaction of MgATP with the sulphonylurea subunit activates ATP sensitive K-channels receptor
Bằng: Gribble, F, et al.
Được phát hành: (1998) -
How ATP inhibits the open K(ATP) channel.
Bằng: Craig, T, et al.
Được phát hành: (2008) -
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Bằng: Reimann, F, et al.
Được phát hành: (2003) -
Mechanism of K-ATP channel inhibition by ATP
Bằng: Ashcroft, F, et al.
Được phát hành: (1998)